[1] 王洁妤, 华琦. 左心室射血分数保留的心力衰竭研究进展[J]. 中华老年心脑血管病杂志, 2016,18(7):766-769.
[2] BROUWERS F P, DE BOER R A, VAN DER HARST P, et al. Incidence and epidemiology of new onset heart failure with preserved VS. reduced ejectionfraction in a community based cohort:11-year follow-up of PREVEND[J]. Eur Heart J, 2013, 34(19): 1424-1431.
[3] CHIRINOS J A.Deciphering systolic-diastolic coupling in the intact heart[J]. Hypertension, 2017,69(4):575-577.
[4] SANTORO A,ALVINO F,ANTONELLI G,et al.Age related diastolic function in amateur athletes[J]. Int J Cardiovasc Imaging,2015,31(3): 567-573.
[5] BAICU C F,ZILE M R,AURIGEMMA G P,et al.Left ventricular systolic performance,function,and contractility in patients with diastolic heart failure[J]. Circulation, 2005,111(18): 2306-2312.
[6] AGIL A, NAVARRO-ALARCÓN M, RUIZ R, et al. Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats[J]. J Pineal Res, 2015,50(2):207-212.
[7] ESPINO J, PARIENTE J A, RODRÍGUEZ A B. Role of melatonin on diabetes-related metabolic disorders[J]. World J Diabetes, 2011,2(6):82-91.
[8] DOMINGUEZRODRIGUEZ A. Melatonin in cardiovascular disease[J]. Expert Opin Investig Drugs, 2012,21(11):1593-1596.
[9] SIMKO F, BEDNAROVA K R, KRAJCIROVICOVA K, et al. Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure[J]. J Pineal Res, 2015, 57(2):177-184.
[10] DOMINGUEZ-RODRIGUEZ A, ABREU-GONZALEZ P, REITER R J. The potential usefulness of serum melatonin level to predict heart failure in patients with hypertensive cardiomyopathy[J]. Int J Cardiol, 2014,174(2):415-417.
[11] BUBENIK G A, KONTUREK S J. Melatonin and aging: Prospects for human treatment[J]. J Physiol Pharmacol, 2011, 62(1):13-19. |
